Skip to main content
Renalytix Plc (AIM:RENX)
London flag London · Delayed Price · Currency is GBP · Price in GBX
3.100
-0.250 (-7.46%)
Mar 9, 2026, 4:35 PM GMT

Renalytix Revenue

In the fiscal year ending June 30, 2025, Renalytix had annual revenue of $3.00M USD with 30.43% growth. Renalytix had revenue of $522.00K in the quarter ending September 30, 2024, with 13.73% growth.

Revenue
$3.00M
Revenue Growth
+35.07%
P/S Ratio
6.19
Revenue / Employee
$65.22K
Employees
46
Market Cap
13.55M GBP

Revenue Chart

* This company reports financials in USD.

History

Fiscal Year End Revenue Change Growth
Jun 30, 20253.00M700.00K30.43%
Jun 30, 20242.30M-1.10M-32.41%
Jun 30, 20233.40M433.00K14.58%
Jun 30, 20222.97M1.48M99.20%
Jun 30, 20211.49M--
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
AstraZeneca 43.64B
GSK plc 32.67B
Haleon 11.03B
Smith & Nephew 4.58B
Cambridge Cognition Holdings 9.05M
Fusion Antibodies 1.60M
genedrive 954.00K
CelLBxHealth 2.62M
Revenue Rankings

Renalytix News

More News